Loading...

Kim, Jayoung

Title(s)Associate Adjunct Professor, Medicine
SchoolMed - Hematology And Oncology
Phone(310) 423-7168
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Kim J, Kim WT, Kim WJ. Advances in urinary biomarker discovery in urological research. Investig Clin Urol. 2020 Feb; 61(Suppl 1):S8-S22. PMID: 32055750.
      View in: PubMed
    2. Kim J. Looking into the clinical application of CD47-targeted near-infrared photoimmunotherapy for human bladder cancer treatment. Transl Androl Urol. 2019 Jul; 8(Suppl 3):S322-S324. PMID: 31392158.
      View in: PubMed
    3. Kim SJ, Kim J, Yoon H. Sexual pain and IC/BPS in women. BMC Urol. 2019 Jun 06; 19(1):47. PMID: 31170952.
      View in: PubMed
    4. Shahid M, Kim M, Lee MY, Yeon A, You S, Kim HL, Kim J. Downregulation of CENPF Remodels Prostate Cancer Cells and Alters Cellular Metabolism. Proteomics. 2019 06; 19(11):e1900038. PMID: 30957416.
      View in: PubMed
    5. Ackerman AL, Anger JT, Khalique MU, Ackerman JE, Tang J, Kim J, Underhill DM, Freeman MR. Optimization of DNA extraction from human urinary samples for mycobiome community profiling. PLoS One. 2019; 14(4):e0210306. PMID: 31022216.
      View in: PubMed
    6. Shahid M, Lee MY, Piplani H, Andres AM, Zhou B, Yeon A, Kim M, Kim HL, Kim J. Centromere protein F (CENPF), a microtubule binding protein, modulates cancer metabolism by regulating pyruvate kinase M2 phosphorylation signaling. Cell Cycle. 2018; 17(24):2802-2818. PMID: 30526248.
      View in: PubMed
    7. Mansour AM, Abdelrahim M, Laymon M, Elsherbeeny M, Sultan M, Shokeir A, Mosbah A, Abol-Enein H, Awadalla A, Cho E, Sairam V, Park TD, Shahid M, Kim J. Epidermal growth factor expression as a predictor of chemotherapeutic resistance in muscle-invasive bladder cancer. BMC Urol. 2018 Nov 09; 18(1):100. PMID: 30413194.
      View in: PubMed
    8. Shahid M, Kim M, Yeon A, Andres AM, You S, Kim J. Quantitative Proteomic Analysis Reveals Caffeine-Perturbed Proteomic Profiles in Normal Bladder Epithelial Cells. Proteomics. 2018 10; 18(20):e1800190. PMID: 30232827.
      View in: PubMed
    9. Jung JH, You S, Oh JW, Yoon J, Yeon A, Shahid M, Cho E, Sairam V, Park TD, Kim KP, Kim J. Integrated proteomic and phosphoproteomic analyses of cisplatin-sensitive and resistant bladder cancer cells reveal CDK2 network as a key therapeutic target. Cancer Lett. 2018 11 28; 437:1-12. PMID: 30145203.
      View in: PubMed
    10. Yeon A, You S, Kim M, Gupta A, Park MH, Weisenberger DJ, Liang G, Kim J. Rewiring of cisplatin-resistant bladder cancer cells through epigenetic regulation of genes involved in amino acid metabolism. Theranostics. 2018; 8(16):4520-4534. PMID: 30214636.
      View in: PubMed
    11. Shahid M, Lee MY, Yeon A, Cho E, Sairam V, Valdiviez L, You S, Kim J. Menthol, a unique urinary volatile compound, is associated with chronic inflammation in interstitial cystitis. Sci Rep. 2018 Jul 18; 8(1):10859. PMID: 30022124.
      View in: PubMed
    12. Wen H, Lee S, Zhu WG, Lee OJ, Yun SJ, Kim J, Park S. Glucose-derived acetate and ACSS2 as key players in cisplatin resistance in bladder cancer. Biochim Biophys Acta Mol Cell Biol Lipids. 2019 03; 1864(3):413-421. PMID: 29883801.
      View in: PubMed
    13. Shahid M, Gull N, Yeon A, Cho E, Bae J, Yoon HS, You S, Yoon H, Kim M, Berman BP, Kim J. Author Correction: Alpha-oxoglutarate inhibits the proliferation of immortalized normal bladder epithelial cells via an epigenetic switch involving ARID1A. Sci Rep. 2018 Apr 16; 8(1):6294. PMID: 29662153.
      View in: PubMed
    14. Kim J. Response to Current Pharmacologic Approaches in Painful Bladder Research: An Update. Int Neurourol J. 2018 Mar; 22(1):72-73. PMID: 29609417.
      View in: PubMed
    15. Shahid M, Gull N, Yeon A, Cho E, Bae J, Yoon HS, You S, Yoon H, Kim M, Berman BP, Kim J. Alpha-oxoglutarate inhibits the proliferation of immortalized normal bladder epithelial cells via an epigenetic switch involving ARID1A. Sci Rep. 2018 03 14; 8(1):4505. PMID: 29540744.
      View in: PubMed
    16. Li P, You S, Nguyen C, Wang Y, Kim J, Sirohi D, Ziembiec A, Luthringer D, Lin SC, Daskivich T, Wu J, Freeman MR, Saouaf R, Li D, Kim HL. Genes involved in prostate cancer progression determine MRI visibility. Theranostics. 2018; 8(7):1752-1765. PMID: 29556354.
      View in: PubMed
    17. Lee JY, Yun SJ, Jeong P, Piao XM, Kim YH, Kim J, Subramaniyam S, Byun YJ, Kang HW, Seo SP, Kim J, Kim JM, Yoo ES, Kim IY, Moon SK, Choi YH, Kim WJ. Identification of differentially expressed miRNAs and miRNA-targeted genes in bladder cancer. Oncotarget. 2018 Jun 12; 9(45):27656-27666. PMID: 29963227.
      View in: PubMed
    18. Kim S, Yeon A, Cho E, Shahid M, Kim J. Effectiveness of a Tailored Colorectal Cancer Educational Seminar in Enhancing the Awareness, Knowledge, and Behavior of Korean Americans Living in the Los Angeles Koreatown Area. Divers Equal Health Care. 2019; 16(1):1-8. PMID: 31019695.
      View in: PubMed
    19. Yun SJ, Kim SK, Kim J, Cha EJ, Kim JS, Kim SJ, Ha YS, Kim YH, Jeong P, Kang HW, Kim JH, Park JL, Choi YK, Moon SK, Choi YH, Kim SY, Kim WJ. Transcriptomic features of primary prostate cancer and their prognostic relevance to castration-resistant prostate cancer. Oncotarget. 2017 Dec 29; 8(70):114845-114855. PMID: 29383125.
      View in: PubMed
    20. Choi BH, You S, Park CS, Cho EH, Park TD, Kim S, Kim YJ, Lee T, Kim J. Differential perturbation of the interstitial cystitis-associated genes of bladder and urethra in rat model. Cell Cycle. 2017 Apr 18; 16(8):749-758. PMID: 28278053.
      View in: PubMed
    21. Li Q, Yin L, Jones LW, Chu GC, Wu JB, Huang JM, Li Q, You S, Kim J, Lu YT, Mrdenovic S, Wang R, Freeman MR, Garraway I, Lewis MS, Chung LW, Zhau HE. Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells. Oncotarget. 2016 Dec 20; 7(51):84645-84657. PMID: 27835867.
      View in: PubMed
    22. Yun SJ, Jeong P, Kang HW, Shinn HK, Kim YH, Yan C, Choi YK, Kim D, Ryu DH, Ha YS, Kim TH, Kwon TG, Kim JM, Suh SH, Kim SK, Kim SY, Kim ST, Kim WT, Lee OJ, Moon SK, Kim NH, Kim IY, Kim J, Cha HJ, Choi YH, Cha EJ, Kim WJ. Erratum: Increased Expression of Herpes Virus-Encoded hsv1-miR-H18 and hsv2-miR-H9-5p in Cancer-Containing Prostate Tissue Compared to That in Benign Prostate Hyperplasia Tissue. Int Neurourol J. 2016 Dec; 20(4):374. PMID: 28043100.
      View in: PubMed
    23. Kim J. Are We Ready to Use the Omics Strategies for Precision Medicine? Int Neurourol J. 2016 Nov; 20(Suppl 2):S65-67. PMID: 27915470.
      View in: PubMed
    24. Kim WT, Yun SJ, Yan C, Jeong P, Kim YH, Lee IS, Kang HW, Park S, Moon SK, Choi YH, Choi YD, Kim IY, Kim J, Kim WJ. Metabolic Pathway Signatures Associated with Urinary Metabolite Biomarkers Differentiate Bladder Cancer Patients from Healthy Controls. Yonsei Med J. 2016 Jul; 57(4):865-71. PMID: 27189278.
      View in: PubMed
    25. Yun SJ, Jeong P, Kang HW, Shinn HK, Kim YH, Yan C, Choi YK, Kim D, Ryu DH, Ha YS, Kim TH, Kwon TG, Kim JM, Suh SH, Kim SK, Kim SY, Kim ST, Kim WT, Lee OJ, Moon SK, Kim NH, Kim IY, Kim J, Cha HJ, Choi YH, Cha EJ, Kim WJ. Increased Expression of Herpes Virus-Encoded hsv1-miR-H18 and hsv2-miR-H9-5p in Cancer-Containing Prostate Tissue Compared to That in Benign Prostate Hyperplasia Tissue. Int Neurourol J. 2016 Jun; 20(2):122-30. PMID: 27377944.
      View in: PubMed
    26. You S, Knudsen BS, Erho N, Alshalalfa M, Takhar M, Al-Deen Ashab H, Davicioni E, Karnes RJ, Klein EA, Den RB, Ross AE, Schaeffer EM, Garraway IP, Kim J, Freeman MR. Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome. Cancer Res. 2016 09 01; 76(17):4948-58. PMID: 27302169.
      View in: PubMed
    27. Kim J. Immune checkpoint blockade therapy for bladder cancer treatment. Investig Clin Urol. 2016 06; 57 Suppl 1:S98-S105. PMID: 27326412.
      View in: PubMed
    28. Chen Z, Kim J. Urinary proteomics and metabolomics studies to monitor bladder health and urological diseases. BMC Urol. 2016 Mar 22; 16:11. PMID: 27000794.
      View in: PubMed
    29. Gururajan M, Cavassani KA, Sievert M, Duan P, Lichterman J, Huang JM, Smith B, You S, Nandana S, Chu GC, Mink S, Josson S, Liu C, Morello M, Jones LW, Kim J, Freeman MR, Bhowmick N, Zhau HE, Chung LW, Posadas EM. SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer. Oncotarget. 2015 Dec 29; 6(42):44072-83. PMID: 26624980.
      View in: PubMed
    30. Kim J, Yun SJ, Kim WJ. Virus encoded circulatory miRNAs for early detection of prostate cancer. BMC Urol. 2015 Nov 26; 15:116. PMID: 26612689.
      View in: PubMed
    31. Griffith JW, Stephens-Shields AJ, Hou X, Naliboff BD, Pontari M, Edwards TC, Williams DA, Clemens JQ, Afari N, Tu F, Lloyd RB, Patrick DL, Mullins C, Kusek JW, Sutcliffe S, Hong BA, Lai HH, Krieger JN, Bradley CS, Kim J, Landis JR. Pain and Urinary Symptoms Should Not be Combined into a Single Score: Psychometric Findings from the MAPP Research Network. J Urol. 2016 Apr; 195(4 Pt 1):949-54. PMID: 26585679.
      View in: PubMed
    32. Jeong P, Ha YS, Yun SJ, Yoon HY, Freeman MR, Kim J, Kim WJ. Assess the expression of ubiquitin specific protease USP2a for bladder cancer diagnosis. BMC Urol. 2015 Aug 07; 15:80. PMID: 26250800.
      View in: PubMed
    33. Kim YW, Yun SJ, Jeong P, Kim SK, Kim SY, Yan C, Seo SP, Lee SK, Kim J, Kim WJ. The c-MET Network as Novel Prognostic Marker for Predicting Bladder Cancer Patients with an Increased Risk of Developing Aggressive Disease. PLoS One. 2015; 10(7):e0134552. PMID: 26225770.
      View in: PubMed
    34. Morley S, You S, Pollan S, Choi J, Zhou B, Hager MH, Steadman K, Spinelli C, Rajendran K, Gertych A, Kim J, Adam RM, Yang W, Krishnan R, Knudsen BS, Di Vizio D, Freeman MR. Regulation of microtubule dynamics by DIAPH3 influences amoeboid tumor cell mechanics and sensitivity to taxanes. Sci Rep. 2015 Jul 16; 5:12136. PMID: 26179371.
      View in: PubMed
    35. Yun SJ, Jeong P, Kang HW, Kim YH, Kim EA, Yan C, Choi YK, Kim D, Kim JM, Kim SK, Kim SY, Kim ST, Kim WT, Lee OJ, Koh GY, Moon SK, Kim IY, Kim J, Choi YH, Kim WJ. Urinary MicroRNAs of Prostate Cancer: Virus-Encoded hsv1-miRH18 and hsv2-miR-H9-5p Could Be Valuable Diagnostic Markers. Int Neurourol J. 2015 Jun; 19(2):74-84. PMID: 26126436.
      View in: PubMed
    36. Jung JH, Lee MY, Choi DY, Lee JW, You S, Lee KY, Kim J, Kim KP. Phospholipids of tumor extracellular vesicles stratify gefitinib-resistant nonsmall cell lung cancer cells from gefitinib-sensitive cells. Proteomics. 2015 Feb; 15(4):824-35. PMID: 25404199.
      View in: PubMed
    37. Wen H, Lee T, You S, Park SH, Song H, Eilber KS, Anger JT, Freeman MR, Park S, Kim J. Urinary metabolite profiling combined with computational analysis predicts interstitial cystitis-associated candidate biomarkers. J Proteome Res. 2015 Jan 02; 14(1):541-8. PMID: 25353990.
      View in: PubMed
    38. Yang W, Ramachandran A, You S, Jeong H, Morley S, Mulone MD, Logvinenko T, Kim J, Hwang D, Freeman MR, Adam RM. Integration of proteomic and transcriptomic profiles identifies a novel PDGF-MYC network in human smooth muscle cells. Cell Commun Signal. 2014 Aug 01; 12:44. PMID: 25080971.
      View in: PubMed
    39. Choi DY, You S, Jung JH, Lee JC, Rho JK, Lee KY, Freeman MR, Kim KP, Kim J. Extracellular vesicles shed from gefitinib-resistant nonsmall cell lung cancer regulate the tumor microenvironment. Proteomics. 2014 Aug; 14(16):1845-56. PMID: 24946052.
      View in: PubMed
    40. Chu GC, Zhau HE, Wang R, Rogatko A, Feng X, Zayzafoon M, Liu Y, Farach-Carson MC, You S, Kim J, Freeman MR, Chung LW. RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization. Endocr Relat Cancer. 2014 Apr; 21(2):311-26. PMID: 24478054.
      View in: PubMed
    41. Kim J, Morley S, Le M, Bedoret D, Umetsu DT, Di Vizio D, Freeman MR. Enhanced shedding of extracellular vesicles from amoeboid prostate cancer cells: potential effects on the tumor microenvironment. Cancer Biol Ther. 2014 Apr; 15(4):409-18. PMID: 24423651.
      View in: PubMed
    42. Shim UJ, Lee IS, Kang HW, Kim J, Kim WT, Kim IY, Ryu KH, Choi YH, Moon SK, Kim YJ, Yun SJ, Lee SC, Kim WJ. Decreased DBC1 Expression Is Associated With Poor Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer. Korean J Urol. 2013 Sep; 54(9):631-7. PMID: 24044099.
      View in: PubMed
    43. Li X, Chen YT, Josson S, Mukhopadhyay NK, Kim J, Freeman MR, Huang WC. MicroRNA-185 and 342 inhibit tumorigenicity and induce apoptosis through blockade of the SREBP metabolic pathway in prostate cancer cells. PLoS One. 2013; 8(8):e70987. PMID: 23951060.
      View in: PubMed
    44. Park JO, Choi DY, Choi DS, Kim HJ, Kang JW, Jung JH, Lee JH, Kim J, Freeman MR, Lee KY, Gho YS, Kim KP. Identification and characterization of proteins isolated from microvesicles derived from human lung cancer pleural effusions. Proteomics. 2013 Jul; 13(14):2125-34. PMID: 23585444.
      View in: PubMed
    45. Choi IS, Yu K, Kim J, De Guzman E, Weisenberger DJ, Oghamian S, Kim HJ, Lee KH, Carroll C, Trinh BN, Kim M, Houshdaran S, Laird PW, Jones PA, Warburton D, Liang G, Koh CJ. Alterations in deoxyribonucleic acid (DNA) methylation patterns of Calca, Timp3, Mmp2, and Igf2r are associated with chronic cystitis in a cyclophosphamide-induced mouse model. Urology. 2013 Jul; 82(1):253.e9-15. PMID: 23806407.
      View in: PubMed
    46. You S, Yang W, Anger JT, Freeman MR, Kim J. 'Omics' approaches to understanding interstitial cystitis/painful bladder syndrome/bladder pain syndrome. Int Neurourol J. 2012 Dec; 16(4):159-68. PMID: 23346481.
      View in: PubMed
    47. Kim J, Keay SK, You S, Loda M, Freeman MR. A synthetic form of frizzled 8-associated antiproliferative factor enhances p53 stability through USP2a and MDM2. PLoS One. 2012; 7(12):e50392. PMID: 23236372.
      View in: PubMed
    48. Kim J, Di Vizio D, Kim TK, Kim J, Kim M, Pelton K, Clinton SK, Hai T, Hwang D, Solomon KR, Freeman MR. The response of the prostate to circulating cholesterol: activating transcription factor 3 (ATF3) as a prominent node in a cholesterol-sensing network. PLoS One. 2012; 7(7):e39448. PMID: 22768301.
      View in: PubMed
    49. Yang W, Kim Y, Kim TK, Keay SK, Kim KP, Steen H, Freeman MR, Hwang D, Kim J. Integration analysis of quantitative proteomics and transcriptomics data identifies potential targets of frizzled-8 protein-related antiproliferative factor in vivo. BJU Int. 2012 Dec; 110(11 Pt C):E1138-46. PMID: 22738385.
      View in: PubMed
    50. Hager MH, Morley S, Bielenberg DR, Gao S, Morello M, Holcomb IN, Liu W, Mouneimne G, Demichelis F, Kim J, Solomon KR, Adam RM, Isaacs WB, Higgs HN, Vessella RL, Di Vizio D, Freeman MR. DIAPH3 governs the cellular transition to the amoeboid tumour phenotype. EMBO Mol Med. 2012 Aug; 4(8):743-60. PMID: 22593025.
      View in: PubMed
    51. Kim J, Kim WJ, Liu Z, Loda M, Freeman MR. The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer. Cell Cycle. 2012 Mar 15; 11(6):1123-30. PMID: 22370483.
      View in: PubMed
    52. Kim J, Freeman MR. Antiproliferative factor signaling and interstitial cystitis/painful bladder syndrome. Int Neurourol J. 2011 Dec; 15(4):184-91. PMID: 22259731.
      View in: PubMed
    53. Freeman MR, Kim J, Lisanti MP, Di Vizio D. A metabolic perturbation by U0126 identifies a role for glutamine in resveratrol-induced cell death. Cancer Biol Ther. 2011 Dec 01; 12(11):966-77. PMID: 22108021.
      View in: PubMed
    54. Yang W, Chung YG, Kim Y, Kim TK, Keay SK, Zhang CO, Ji M, Hwang D, Kim KP, Steen H, Freeman MR, Kim J. Quantitative proteomics identifies a beta-catenin network as an element of the signaling response to Frizzled-8 protein-related antiproliferative factor. Mol Cell Proteomics. 2011 Jun; 10(6):M110.007492. PMID: 21422242.
      View in: PubMed
    55. Kim J, Ji M, DiDonato JA, Rackley RR, Kuang M, Sadhukhan PC, Mauney JR, Keay SK, Freeman MR, Liou LS, Adam RM. An hTERT-immortalized human urothelial cell line that responds to anti-proliferative factor. In Vitro Cell Dev Biol Anim. 2011 Jan; 47(1):2-9. PMID: 21136194.
      View in: PubMed
    56. Yang W, Cai Q, Lui VW, Everley PA, Kim J, Bhola N, Quesnelle KM, Zetter BR, Steen H, Freeman MR, Grandis JR. Quantitative proteomics analysis reveals molecular networks regulated by epidermal growth factor receptor level in head and neck cancer. J Proteome Res. 2010 Jun 04; 9(6):3073-82. PMID: 20426488.
      View in: PubMed
    57. Di Vizio D, Kim J, Hager MH, Morello M, Yang W, Lafargue CJ, True LD, Rubin MA, Adam RM, Beroukhim R, Demichelis F, Freeman MR. Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res. 2009 Jul 01; 69(13):5601-9. PMID: 19549916.
      View in: PubMed
    58. Kim J, Yanagihara Y, Kikugawa T, Ji M, Tanji N, Masayoshi Y, Freeman MR. A signaling network in phenylephrine-induced benign prostatic hyperplasia. Endocrinology. 2009 Aug; 150(8):3576-83. PMID: 19443575.
      View in: PubMed
    59. Mukhopadhyay NK, Kim J, Cinar B, Ramachandran A, Hager MH, Di Vizio D, Adam RM, Rubin MA, Raychaudhuri P, De Benedetti A, Freeman MR. Heterogeneous nuclear ribonucleoprotein K is a novel regulator of androgen receptor translation. Cancer Res. 2009 Mar 15; 69(6):2210-8. PMID: 19258514.
      View in: PubMed
    60. Solomon KR, Pelton K, Boucher K, Joo J, Tully C, Zurakowski D, Schaffner CP, Kim J, Freeman MR. Ezetimibe is an inhibitor of tumor angiogenesis. Am J Pathol. 2009 Mar; 174(3):1017-26. PMID: 19179610.
      View in: PubMed
    61. Kim J, Keay SK, Freeman MR. Heparin-binding epidermal growth factor-like growth factor functionally antagonizes interstitial cystitis antiproliferative factor via mitogen-activated protein kinase pathway activation. BJU Int. 2009 Feb; 103(4):541-6. PMID: 18990151.
      View in: PubMed
    62. Di Vizio D, Adam RM, Kim J, Kim R, Sotgia F, Williams T, Demichelis F, Solomon KR, Loda M, Rubin MA, Lisanti MP, Freeman MR. Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase. Cell Cycle. 2008 Jul 15; 7(14):2257-67. PMID: 18635971.
      View in: PubMed
    63. Kim J, Jahng WJ, Di Vizio D, Lee JS, Jhaveri R, Rubin MA, Shisheva A, Freeman MR. The phosphoinositide kinase PIKfyve mediates epidermal growth factor receptor trafficking to the nucleus. Cancer Res. 2007 Oct 01; 67(19):9229-37. PMID: 17909029.
      View in: PubMed
    64. Kim J, Keay SK, Dimitrakov JD, Freeman MR. p53 mediates interstitial cystitis antiproliferative factor (APF)-induced growth inhibition of human urothelial cells. FEBS Lett. 2007 Aug 07; 581(20):3795-9. PMID: 17628545.
      View in: PubMed
    65. Adam RM, Mukhopadhyay NK, Kim J, Di Vizio D, Cinar B, Boucher K, Solomon KR, Freeman MR. Cholesterol sensitivity of endogenous and myristoylated Akt. Cancer Res. 2007 Jul 01; 67(13):6238-46. PMID: 17616681.
      View in: PubMed
    66. Mukhopadhyay NK, Cinar B, Mukhopadhyay L, Lutchman M, Ferdinand AS, Kim J, Chung LW, Adam RM, Ray SK, Leiter AB, Richie JP, Liu BC, Freeman MR. The zinc finger protein ras-responsive element binding protein-1 is a coregulator of the androgen receptor: implications for the role of the Ras pathway in enhancing androgenic signaling in prostate cancer. Mol Endocrinol. 2007 Sep; 21(9):2056-70. PMID: 17550981.
      View in: PubMed
    67. Park YS, Kim J, Misonou Y, Takamiya R, Takahashi M, Freeman MR, Taniguchi N. Acrolein induces cyclooxygenase-2 and prostaglandin production in human umbilical vein endothelial cells: roles of p38 MAP kinase. Arterioscler Thromb Vasc Biol. 2007 Jun; 27(6):1319-25. PMID: 17363696.
      View in: PubMed
    68. Freeman MR, Cinar B, Kim J, Mukhopadhyay NK, Di Vizio D, Adam RM, Solomon KR. Transit of hormonal and EGF receptor-dependent signals through cholesterol-rich membranes. Steroids. 2007 Feb; 72(2):210-7. PMID: 17173942.
      View in: PubMed
    69. Kim J, Adam RM, Freeman MR. Trafficking of nuclear heparin-binding epidermal growth factor-like growth factor into an epidermal growth factor receptor-dependent autocrine loop in response to oxidative stress. Cancer Res. 2005 Sep 15; 65(18):8242-9. PMID: 16166300.
      View in: PubMed
    70. Zhuang L, Kim J, Adam RM, Solomon KR, Freeman MR. Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J Clin Invest. 2005 Apr; 115(4):959-68. PMID: 15776112.
      View in: PubMed
    71. Kim J, Lin J, Adam RM, Lamb C, Shively SB, Freeman MR. An oxidative stress mechanism mediates chelerythrine-induced heparin-binding EGF-like growth factor ectodomain shedding. J Cell Biochem. 2005 Jan 01; 94(1):39-49. PMID: 15490481.
      View in: PubMed
    72. Kim J, Adam RM, Solomon KR, Freeman MR. Involvement of cholesterol-rich lipid rafts in interleukin-6-induced neuroendocrine differentiation of LNCaP prostate cancer cells. Endocrinology. 2004 Feb; 145(2):613-9. PMID: 14563701.
      View in: PubMed
    73. Kim J, Freeman MR. JNK/SAPK mediates doxorubicin-induced differentiation and apoptosis in MCF-7 breast cancer cells. Breast Cancer Res Treat. 2003 Jun; 79(3):321-8. PMID: 12846416.
      View in: PubMed
    74. Adam RM, Kim J, Lin J, Orsola A, Zhuang L, Rice DC, Freeman MR. Heparin-binding epidermal growth factor-like growth factor stimulates androgen-independent prostate tumor growth and antagonizes androgen receptor function. Endocrinology. 2002 Dec; 143(12):4599-608. PMID: 12446587.
      View in: PubMed
    75. Kim J, Adam RM, Freeman MR. Activation of the Erk mitogen-activated protein kinase pathway stimulates neuroendocrine differentiation in LNCaP cells independently of cell cycle withdrawal and STAT3 phosphorylation. Cancer Res. 2002 Mar 01; 62(5):1549-54. PMID: 11888934.
      View in: PubMed